Phytochemicals in thyroid cancer: analysis of the preclinical studies
Purpose In the search for novel effective compounds to use in thyroid cancer (TC) unresponsive to current treatment, attention has recently focused on plant-derived compounds with anticancer activity. In this review, we discuss the preclinical studies demonstrating phytochemical activity against thy...
Gespeichert in:
Veröffentlicht in: | Endocrine 2021-07, Vol.73 (1), p.8-15 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 15 |
---|---|
container_issue | 1 |
container_start_page | 8 |
container_title | Endocrine |
container_volume | 73 |
creator | Bulotta, Stefania Capriglione, Francesca Celano, Marilena Pecce, Valeria Russo, Diego Maggisano, Valentina |
description | Purpose
In the search for novel effective compounds to use in thyroid cancer (TC) unresponsive to current treatment, attention has recently focused on plant-derived compounds with anticancer activity. In this review, we discuss the preclinical studies demonstrating phytochemical activity against thyroid cancer cells.
Results/Conclusions
In particular, we describe their antiproliferative properties or ability to re-induce iodine retention, thus supporting their potential use as single agents or adjuvants in radioiodine-resistant thyroid cancer treatment. |
doi_str_mv | 10.1007/s12020-021-02651-y |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2489601325</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2489601325</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-39eacf317794c1cc4dde427822c932c4f900852b7593b0cec587b820682e78783</originalsourceid><addsrcrecordid>eNp9kM1KxDAUhYMojo6-gAspuHFTTW6aJnUnw_gDA7pQcBfa9NbJ0GnHpF307c3YUcGFi3AD5zsnN4eQM0avGKXy2jOgQGMKLJxUsHjYI0dMiCymQd8Pdy5ETKl6m5Bj71eUAkAqD8mEc6EkCHFE5s_LoWvNEtfW5LWPbBN1y8G1toxM3hh0N1He5PXgrY_aKmgYbRya2jZbPvJdX1r0J-SgCm483c0peb2bv8we4sXT_ePsdhEbLkUX8wxzU3EmZZYYZkxSlpiAVAAm42CSKgvLCiikyHhBDZqwZaGApgpQKqn4lFyOuRvXfvToO7223mBd5w22vdeQqCyljIMI6MUfdNX2LnwlUCIBrlgYgYKRMq713mGlN86uczdoRvW2ZD2WrEPJ-qtkPQTT-S66L9ZY_li-Ww0AHwEfpOYd3e_b_8R-Amlshmg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2542381254</pqid></control><display><type>article</type><title>Phytochemicals in thyroid cancer: analysis of the preclinical studies</title><source>SpringerLink Journals</source><creator>Bulotta, Stefania ; Capriglione, Francesca ; Celano, Marilena ; Pecce, Valeria ; Russo, Diego ; Maggisano, Valentina</creator><creatorcontrib>Bulotta, Stefania ; Capriglione, Francesca ; Celano, Marilena ; Pecce, Valeria ; Russo, Diego ; Maggisano, Valentina</creatorcontrib><description>Purpose
In the search for novel effective compounds to use in thyroid cancer (TC) unresponsive to current treatment, attention has recently focused on plant-derived compounds with anticancer activity. In this review, we discuss the preclinical studies demonstrating phytochemical activity against thyroid cancer cells.
Results/Conclusions
In particular, we describe their antiproliferative properties or ability to re-induce iodine retention, thus supporting their potential use as single agents or adjuvants in radioiodine-resistant thyroid cancer treatment.</description><identifier>ISSN: 1355-008X</identifier><identifier>EISSN: 1559-0100</identifier><identifier>DOI: 10.1007/s12020-021-02651-y</identifier><identifier>PMID: 33587255</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adjuvants ; Antitumor activity ; Diabetes ; Endocrinology ; Humanities and Social Sciences ; Internal Medicine ; Iodine ; Medicine ; Medicine & Public Health ; multidisciplinary ; Phytochemicals ; Plants ; Review ; Science ; Thyroid cancer</subject><ispartof>Endocrine, 2021-07, Vol.73 (1), p.8-15</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021</rights><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-39eacf317794c1cc4dde427822c932c4f900852b7593b0cec587b820682e78783</citedby><cites>FETCH-LOGICAL-c375t-39eacf317794c1cc4dde427822c932c4f900852b7593b0cec587b820682e78783</cites><orcidid>0000-0001-7559-1595</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12020-021-02651-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12020-021-02651-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33587255$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bulotta, Stefania</creatorcontrib><creatorcontrib>Capriglione, Francesca</creatorcontrib><creatorcontrib>Celano, Marilena</creatorcontrib><creatorcontrib>Pecce, Valeria</creatorcontrib><creatorcontrib>Russo, Diego</creatorcontrib><creatorcontrib>Maggisano, Valentina</creatorcontrib><title>Phytochemicals in thyroid cancer: analysis of the preclinical studies</title><title>Endocrine</title><addtitle>Endocrine</addtitle><addtitle>Endocrine</addtitle><description>Purpose
In the search for novel effective compounds to use in thyroid cancer (TC) unresponsive to current treatment, attention has recently focused on plant-derived compounds with anticancer activity. In this review, we discuss the preclinical studies demonstrating phytochemical activity against thyroid cancer cells.
Results/Conclusions
In particular, we describe their antiproliferative properties or ability to re-induce iodine retention, thus supporting their potential use as single agents or adjuvants in radioiodine-resistant thyroid cancer treatment.</description><subject>Adjuvants</subject><subject>Antitumor activity</subject><subject>Diabetes</subject><subject>Endocrinology</subject><subject>Humanities and Social Sciences</subject><subject>Internal Medicine</subject><subject>Iodine</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>multidisciplinary</subject><subject>Phytochemicals</subject><subject>Plants</subject><subject>Review</subject><subject>Science</subject><subject>Thyroid cancer</subject><issn>1355-008X</issn><issn>1559-0100</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kM1KxDAUhYMojo6-gAspuHFTTW6aJnUnw_gDA7pQcBfa9NbJ0GnHpF307c3YUcGFi3AD5zsnN4eQM0avGKXy2jOgQGMKLJxUsHjYI0dMiCymQd8Pdy5ETKl6m5Bj71eUAkAqD8mEc6EkCHFE5s_LoWvNEtfW5LWPbBN1y8G1toxM3hh0N1He5PXgrY_aKmgYbRya2jZbPvJdX1r0J-SgCm483c0peb2bv8we4sXT_ePsdhEbLkUX8wxzU3EmZZYYZkxSlpiAVAAm42CSKgvLCiikyHhBDZqwZaGApgpQKqn4lFyOuRvXfvToO7223mBd5w22vdeQqCyljIMI6MUfdNX2LnwlUCIBrlgYgYKRMq713mGlN86uczdoRvW2ZD2WrEPJ-qtkPQTT-S66L9ZY_li-Ww0AHwEfpOYd3e_b_8R-Amlshmg</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Bulotta, Stefania</creator><creator>Capriglione, Francesca</creator><creator>Celano, Marilena</creator><creator>Pecce, Valeria</creator><creator>Russo, Diego</creator><creator>Maggisano, Valentina</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7559-1595</orcidid></search><sort><creationdate>20210701</creationdate><title>Phytochemicals in thyroid cancer: analysis of the preclinical studies</title><author>Bulotta, Stefania ; Capriglione, Francesca ; Celano, Marilena ; Pecce, Valeria ; Russo, Diego ; Maggisano, Valentina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-39eacf317794c1cc4dde427822c932c4f900852b7593b0cec587b820682e78783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adjuvants</topic><topic>Antitumor activity</topic><topic>Diabetes</topic><topic>Endocrinology</topic><topic>Humanities and Social Sciences</topic><topic>Internal Medicine</topic><topic>Iodine</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>multidisciplinary</topic><topic>Phytochemicals</topic><topic>Plants</topic><topic>Review</topic><topic>Science</topic><topic>Thyroid cancer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bulotta, Stefania</creatorcontrib><creatorcontrib>Capriglione, Francesca</creatorcontrib><creatorcontrib>Celano, Marilena</creatorcontrib><creatorcontrib>Pecce, Valeria</creatorcontrib><creatorcontrib>Russo, Diego</creatorcontrib><creatorcontrib>Maggisano, Valentina</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bulotta, Stefania</au><au>Capriglione, Francesca</au><au>Celano, Marilena</au><au>Pecce, Valeria</au><au>Russo, Diego</au><au>Maggisano, Valentina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phytochemicals in thyroid cancer: analysis of the preclinical studies</atitle><jtitle>Endocrine</jtitle><stitle>Endocrine</stitle><addtitle>Endocrine</addtitle><date>2021-07-01</date><risdate>2021</risdate><volume>73</volume><issue>1</issue><spage>8</spage><epage>15</epage><pages>8-15</pages><issn>1355-008X</issn><eissn>1559-0100</eissn><abstract>Purpose
In the search for novel effective compounds to use in thyroid cancer (TC) unresponsive to current treatment, attention has recently focused on plant-derived compounds with anticancer activity. In this review, we discuss the preclinical studies demonstrating phytochemical activity against thyroid cancer cells.
Results/Conclusions
In particular, we describe their antiproliferative properties or ability to re-induce iodine retention, thus supporting their potential use as single agents or adjuvants in radioiodine-resistant thyroid cancer treatment.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>33587255</pmid><doi>10.1007/s12020-021-02651-y</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-7559-1595</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1355-008X |
ispartof | Endocrine, 2021-07, Vol.73 (1), p.8-15 |
issn | 1355-008X 1559-0100 |
language | eng |
recordid | cdi_proquest_miscellaneous_2489601325 |
source | SpringerLink Journals |
subjects | Adjuvants Antitumor activity Diabetes Endocrinology Humanities and Social Sciences Internal Medicine Iodine Medicine Medicine & Public Health multidisciplinary Phytochemicals Plants Review Science Thyroid cancer |
title | Phytochemicals in thyroid cancer: analysis of the preclinical studies |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T06%3A38%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phytochemicals%20in%20thyroid%20cancer:%20analysis%20of%20the%20preclinical%20studies&rft.jtitle=Endocrine&rft.au=Bulotta,%20Stefania&rft.date=2021-07-01&rft.volume=73&rft.issue=1&rft.spage=8&rft.epage=15&rft.pages=8-15&rft.issn=1355-008X&rft.eissn=1559-0100&rft_id=info:doi/10.1007/s12020-021-02651-y&rft_dat=%3Cproquest_cross%3E2489601325%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2542381254&rft_id=info:pmid/33587255&rfr_iscdi=true |